We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+4.39%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.04B
AUM Growth
+$1.26B
Cap. Flow
+$1.24B
Cap. Flow %
24.63%
Top 10 Hldgs %
29.33%
Holding
6,215
New
531
Increased
2,728
Reduced
2,144
Closed
536

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$165M
2
MSFT icon
Microsoft
MSFT
+$143M
3
NVDA icon
NVIDIA
NVDA
+$128M
4
AMZN icon
Amazon
AMZN
+$86.4M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$63.4M

Sector Composition

Rank Sector Weight
1 Technology 28.99%
2 Financials 11.06%
3 Consumer Discretionary 10.07%
4 Communication Services 8.96%
5 Healthcare 8.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HYPD
4551
Hyperion DeFi Inc
HYPD
$40M
$3.99K ﹤0.01%
341
+217
+175% +$5.23K
STRM
4552
DELISTED
Streamline Health Solutions
STRM
$3.99K ﹤0.01%
1,060
-106
-9% -$299
AIMD icon
4553
Ainos
AIMD
$10.9M
$3.98K ﹤0.01%
1,747
-6
-0.3% -$14
ZSQR
4554
Z Squared Inc
ZSQR
$204M
$3.98K ﹤0.01%
723
+244
+51% +$941
KPRX icon
4555
Kiora Pharmaceuticals
KPRX
$11.6M
$3.98K ﹤0.01%
1,205
-749
-38% -$2.59K
DALI icon
4556
First Trust DorseyWright DALI 1 ETF
DALI
$100M
$3.98K ﹤0.01%
154
BENF icon
4557
Beneficient
BENF
$39.8M
$3.97K ﹤0.01%
667
-2
-0.3% -$17
IBIO icon
4558
iBio
IBIO
$73M
$3.97K ﹤0.01%
1,621
-583
-26% -$1.5K
CYTH
4559
DELISTED
Cyclo Therapeutics, Inc. Common Stock
CYTH
$3.94K ﹤0.01%
6,684
+1,289
+24% +$894
CHRN
4560
ChronoScale Holdings
CHRN
$2.8B
$3.94K ﹤0.01%
431
+357
+482% +$4.4K
SYPR icon
4561
Sypris Solutions
SYPR
$48.1M
$3.92K ﹤0.01%
2,204
-721
-25% -$1.13K
MRKR icon
4562
Marker Therapeutics
MRKR
$18.7M
$3.92K ﹤0.01%
1,260
-248
-16% -$878
SLNH icon
4563
Soluna Holdings
SLNH
$200M
$3.92K ﹤0.01%
1,866
-91
-5% -$301
UAVS icon
4564
AgEagle Aerial Systems
UAVS
$58.3M
$3.92K ﹤0.01%
1,129
+468
+71% +$1.91K
BIVI icon
4565
BioVie
BIVI
$9.58M
$3.91K ﹤0.01%
196
-132
-40% -$3.18K
TAIT
4566
DELISTED
Taitron Components
TAIT
$3.91K ﹤0.01%
1,516
-55
-4% -$152
RFAI
4567
RF Acquisition Corp II
RFAI
$92.7M
$3.9K ﹤0.01%
+382
New +$3.89K
HCTI icon
4568
Healthcare Triangle
HCTI
$2.58M
-1
Closed -$12.6K
UPXI icon
4569
Upexi
UPXI
$58.9M
$3.89K ﹤0.01%
1,109
+468
+73% +$2.17K
FLYX icon
4570
flyExclusive
FLYX
$68.4M
$3.89K ﹤0.01%
1,234
-237
-16% -$568
RIME
4571
Algorhythm Holdings
RIME
$6.65M
$3.88K ﹤0.01%
220
+182
+479% +$10.1K
GOEV
4572
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$3.87K ﹤0.01%
2,744
+2,230
+434% +$24.3K
RDI icon
4573
Reading International Class A
RDI
$33.2M
$3.84K ﹤0.01%
2,912
+32
+1% +$47
EOI
4574
Eaton Vance Enhanced Equity Income Fund
EOI
$830M
$3.84K ﹤0.01%
+185
New +$3.85K
PMCB icon
4575
PharmaCyte Biotech
PMCB
$5.9M
$3.84K ﹤0.01%
2,445
-415
-15% -$716

Similar funds

Tower Research Capital (TRC)'s Q4 2024 Portfolio in Review

As of Q4 2024, Tower Research Capital (TRC) held 6,215 positions worth $5.04B, up 33% from $3.78B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $1.24B of net new capital in Q4 2024, opening 531 new positions and adding to 2,728 existing holdings. Its largest new stake was iShares MSCI USA Min Vol Factor ETF: 67,476 shares worth $5.99M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $296M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2024 buy was iShares MSCI USA Min Vol Factor ETF: 67,476 shares worth $5.99M.
  • Tower Research Capital (TRC) added most to Apple in Q4 2024, an estimated $165M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2024 reduction was Invesco QQQ Trust, cutting an estimated $296M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 ETF in Q4 2024, selling an estimated $30.5M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $5.04B portfolio in Q4 2024.
  • Tower Research Capital (TRC) opened 531 new positions and closed 536 in Q4 2024.
  • Tower Research Capital (TRC)'s portfolio value rose 33% quarter-over-quarter to $5.04B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2024, filed 13 Feb 2025.